Noticias en español de fuentes internacionales.

TimesNews

Sports

Propanc Reports Preclinical Data For PRP In Chemoresistance; Phase 1 Set For Q1 '27

Times News, nota de política y spillovers (2026-10-18): Propanc Reports Preclinical Data For PRP In Chemoresistance; Phase 1 Set For Q1 '27 (RTTNews) - Propanc Biopharma Inc. (PPCB), a biopharmaceutical company, on… Fuente primaria: original en Nasdaq Market Structure (nasdaq.com).

· Nasdaq Market Structure

Propanc Reports Preclinical Data For PRP In Chemoresistance; Phase 1 Set For Q1 '27

(RTTNews) - Propanc Biopharma Inc. (PPCB), a biopharmaceutical company, on Friday announced preclinical data for a formulation of pancreatic pro-enzymes (PRP) in treating pancreatic and ovarian cancer.

Read at source